Single-stock moves reflected event-driven trading. Vanda Pharmaceuticals surged after the US FDA approved its motion-sickness treatment tradipitant. Axsome Therapeutics jumped...
Market participants increased exposure to domestically focused stocks ahead of next week’s decision. Strategists noted that small-cap shares reacted positively...